Wednesday - May 27, 2026
Kirkland Advises Eli Lilly on Acquisition of LimmaTech Biologics
May 26, 2026
CHICAGO, Illinois, May 26 [Category: BizLaw/Legal] -- Kirkland and Ellis, a law firm, issued the following news release:

* * *

Kirkland Advises Eli Lilly on Acquisition of LimmaTech Biologics

*

Kirkland & Ellis advised Eli Lilly and Company (NYSE: LLY) on the acquisition of LimmaTech Biologics AG. Under the terms of the agreement, Lilly will acquire LimmaTech for up to $780 million in cash, inclusive of an upfront payment and additional pot . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products